MedPath

SORE Study: Sitz Baths After Urogynecologic Reconstruction

Not Applicable
Recruiting
Conditions
Pelvic Organ Prolapse
Postoperative Pain Management
Gynecologic Surgeries
Registration Number
NCT07215780
Lead Sponsor
Yale University
Brief Summary

The purpose of this study is to evaluate the utility of postoperative sitz baths in patient pain perception and recovery following surgical repair of prolapse. The SORE Study is a prospective, randomized controlled trial that aims to compare postoperative pain intensity one week after native tissue repair of pelvic organ prolapse for patients undergoing a sitz bath regimen versus usual care. Findings from this study may contribute to more robust, multimodal postoperative pain management plans if proven efficacious or, alternatively, reduce plastic medical waste and simplify postoperative pain plans if found to be ineffective.

Detailed Description

The primary objective of the SORE study is to compare postoperative pain intensity one week after native tissue repair of pelvic organ prolapse for patients undergoing a sitz bath regimen versus usual care.

The secondary objectives of this study are to evaluate patient satisfaction with pain management after native tissue prolapse repair (and specifically posterior repair and/or perineorrhaphy), patient-reported opioid requirements, healthcare utilization, postoperative pain plan adherence, and incisional healing and complications between those undergoing a sitz bath regimen versus usual care.

Recruitment & Eligibility

Status
RECRUITING
Sex
Female
Target Recruitment
112
Inclusion Criteria
  • Female ≥ 18 years of age at time of surgery
  • English-speaking
  • Documentation of pelvic organ prolapse as evidenced by Stage 2, 3, or 4 prolapse on preoperative Pelvic Organ Prolapse Quantification system (POP-Q) examination
  • Surgery to be performed by a urogynecologist
  • Ambulatory or inpatient surgery acceptable
Exclusion Criteria
  • Mesh-augmented prolapse repair (robotic, laparoscopic, or open sacrocolpopexy or sacrohysteropexy, vaginal mesh)
  • Urogynecologic surgery without prolapse repair (i.e. midurethral sling, intravesicular botox, hysterectomy only)
  • Suspected genital herpes simplex virus (HSV), molluscum contagiosum virus (MCV), condyloma acuminata, or vulvar/vaginal skin and soft tissue infection at recruitment by patient report
  • Daily opioid use (short or long-acting)
  • Concurrent non-urogynecologic surgery (i.e. rectopexy, staging or debulking for malignancy)
  • Lack of access to operative report
  • Pregnant (as determined by positive urine pregnancy test on the day of surgery via standard testing or current pregnancy documented in the preoperative note)
  • Incarcerated
  • Unable to give consent/conserved
  • Unable to complete study intervention or assessment per investigators

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Patient-Reported Outcomes Measurement Information System Pain Intensity (PROMIS-PI) short form 3a questionnaireDay 7 Post surgery

Pain intensity will be assessed on a 15-point scale evaluating current, worst, and average pain on postoperative day 7 following prolapse repair and converted to a T- score using general population data. Higher scores indicate increased pain intensity.

Secondary Outcome Measures
NameTimeMethod
Mean score patient satisfactionDay 7 Post surgery

Satisfaction with postoperative pain management on a 0-100 mm visual analog scale

Mean Oxycodone useDay 7 Post surgery

Mean number of oxycodone tablets used postoperatively

Comfort with postoperative pain planDay 7 Post surgery

Participant comfort level with managing postoperative multimodal pain plan on a 5-point Likert scale (1 = very uncomfortable, 5 = very comfortable)

Comfort with postoperative pain plan using Sitz bathDay 7 Post surgery

Participant comfort with sitz bath setup and cleanup, accessibility to bathroom use, physical comfort during and after use of sitz bath on a 5-point Likert scale (1 = very uncomfortable, 5 = very comfortable)

Sitz bath use- AdherenceDay 7 Post surgery

Total use of sitz baths in minutes

Barriers to use- AdherenceDay 7 Post surgery

Number of barriers to use perceived by self-report

Number of participants with rare adverse effectsDay 7 Post surgery

Number of participants with any rare adverse effects per protocol

Mean Opioid useDay 7 Post surgery

Mean number of requests for opioid refills postoperatively

Mean number of calls regarding painUp to Day 90 Post surgery

Mean number of calls or messages for postoperative pain within 90 days of surgery via review of medical record

Mean number of Emergency Department visitsUp to Day 90 Post surgery

Mean number of emergency department visits within 90 days of surgery via review of medical record

Trial Locations

Locations (4)

Bridgeport Hospital

🇺🇸

Bridgeport, Connecticut, United States

Greenwich Hospital

🇺🇸

Greenwich, Connecticut, United States

Yale-New Haven Hospital

🇺🇸

New Haven, Connecticut, United States

Lawrence + Memorial Hospital

🇺🇸

New London, Connecticut, United States

Bridgeport Hospital
🇺🇸Bridgeport, Connecticut, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.